Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents

Outcomes for patients with multiple myeloma (MM) have improved in recent years owing to use of novel agents and high-dose therapy followed by autologous stem cell transplant (ASCT). We analyzed the outcomes of 511 consecutive patients treated with novel therapies at our institution between 2006 and...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Leukemia
Κύριοι συγγραφείς: Majithia, N, Rajkumar, SV, Lacy, MQ, Buadi, FK, Dispenzieri, A, Gertz, MA, Hayman, SR, Dingli, D, Kapoor, P, Hwa, L, Lust, JA, Russell, SJ, Go, RS, Kyle, RA, Kumar, SK
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2016
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5541860/
https://ncbi.nlm.nih.gov/pubmed/27211270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2016.147
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια